Company Revenue

The company grew nearly 65% in the first quarter of 2026 due to rapid surgeon onboarding and expanding product indications....

The company grew double-digits in the first quarter of 2026 thanks to its broadening procedural footprint and expanding commercial scale....

The company grew more than 50% in the first quarter of 2026 as its personalized lumbar and cervical systems gain...

The company's sales declined more than 10% as its mix shifts away from Lapiplasty toward lower-cost MIS bunion systems....

The company's base business grew 13.2% in the first quarter of 2026, driven by continued strength in spine and resurgent...

The company grew in the high single digits in the first quarter of 2026 due to broad strength across its...

The company grew nearly 11% on a reported basis in the first quarter of 2026, driven by shoulder and hip...

The company grew in the low teens during the first quarter of 2026 as it drove strong surgical sales results,...

The company grew in the high single digits in the first quarter of 2026 on the strength of hips and...

The company grew in the low-single digits on a reported basis but saw promising signs from its spinal implant business....